Natural gas prices are testing resistance at $3.00-$3.05 and could rise to $3.20-$3.25 if they break above this level. On the downside, a drop below $3.00 could push prices toward $2.75-$2.80. Meanwhile, WTI oil prices are retreating as Saudi Aramco cuts prices for Asian buyers and geopolitical tensions rise with potential conflict in Yemen. Brent oil is also falling, testing the $100 level amid hopes for US-Iran negotiations and increased oil flow through the Strait of Hormuz. These movements reflect ongoing geopolitical risks and supply adjustments impacting energy markets.
Natural gas and oil price forecasts show natural gas testing resistance at $3.00-$3.05, with potential moves to $3.20-$3.25 if breached, while WTI and Brent oil prices are falling amid Saudi Aramco's price cuts and geopolitical tensions. For readers following US stocks on Pluang, here is the market snapshot as of Oct 06, 2026 01:21 WIB: out of 150 priced stocks, 91 rose and 59 fell. Notable movers include Bristol-Myers Squibb Co (BMY) down 4.09%, Halliburton Company (HAL) up 3.86%, and GameStop Corp. (GME) up 3.85% with strong sell activity.
BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...
Raymond James increased its price target for SBA Communications to $271 from $264, signaling a 68.6% upside from the current share price of $160.74. The growth is driven by rising mobile data demand, network expansions by wireless carriers, and stead...
Antimony Resources Corp. has closed a flow-through financing, issuing over 10.6 million shares at $0.47 each, raising $5 million to fund exploration and development of its Bald Hill Antimony Project in New Brunswick, Canada. Bald Hill is noted as the...
NVIDIA stock reached a new all-time high, rising 28% year to date, driven by strong AI demand signals, including Foxconn's record revenue month attributed to AI product growth. Taiwan Semiconductor and Broadcom shares also rose, supporting the bullis...
Novavax shares surged 22% following Sanofi's rollout of the Nuvaxovid COVID-19 vaccine for the fall season, giving Novavax a commercial boost through its licensing deal. Unlike Moderna and BioNTech, Novavax earns royalties from Sanofi's sales rather ...
